All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Reference Result Outcome | NCIT_C94038 | [Data or information that is determined by an act of observation.] |
| Outcome | NCIT_C20200 | [The result of an action.] |
| Reference Result Target Anatomic Site Code | NCIT_C94039 | [A coded value specifying the anatomic location that is the focus of a reference result.] |
| Target Anatomic Site Code | NCIT_C93690 | [A coded value specifying the anatomic location that is the focus of the entity or activity.] |
| CD5-Positive Neoplastic Cells Present | NCIT_C69080 | |
| Immunophenotypic Finding | NCIT_C40998 | |
| CD5 Positive | NCIT_C131063 | [Indicates that CD5 expression has been detected in a sample.] |
| CD23-Positive Neoplastic Cells Present | NCIT_C69081 | |
| FCER2 Positive | NCIT_C132231 | [Indicates that FCER2 expression has been detected in a sample.] |
| BCR-ABL p210-b3a2 Breakpoint-derived Pentapeptide Vaccine | NCIT_C69082 | [A multipeptide vaccine consisting of five peptides derived from the bcr-abl p210-b3a2 breakpoint fusion protein with potential antineoplastic activity. Vaccination with bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells that express the bcr-abl p210-b3a2 breakpoint fusion protein. In chronic myelogenous leukemia (CML), fusion genes typically result from the fusion of either bcr exon b2 or exon b3 to abl exon a2, resulting in either a b3a2 or a b2a2 gene fusion product.] |
| BCR-ABL Peptide Vaccine | NCIT_C2205 | [A multivalent antineoplastic vaccine comprised of the bcr-abl oncogene breakpoint fusion peptide that elicits a bcr-abl specific T-cell immune response. (NCI04)] |
| Unit of Specific Heat Capacity | NCIT_C69083 | [A unit for measurement of the heat energy required to increase the temperature of a unit quantity of a substance by a certain temperature interval (usually by one degree). The specific heat of substances is typically measured under constant pressure or at constant volume.] |
| Calorie per Gram | NCIT_C69084 | [The amount of heat required to raise the temperature of one gram of water by one degree Celsius.] |
| Assortment | NCIT_C69085 | [A collection of things containing a variety of sorts or kinds, a variety.] |
| Item Collection | NCIT_C45261 | [A group of items of the same type, gathered for display or study.] |
| Ocular System Dosing Unit | NCIT_C69086 | [A dosing unit equal to the amount of active ingredient(s) in an ocular system.] |
| Potency Unit | NCIT_C48470 | [The basic quantity or increment used to describe the strength of a product or amount of product in a package.] |
| Product Pre-1938 Indicator | NCIT_C94030 | [Specifies whether the product qualifies under the 1938 Grandfather Clause, contained in section 20l(p)(l) of the U.S. Federal Food, Drug and Cosmetic Act.] |
| Pre-1938 Indicator | NCIT_C93630 | [Specifies whether the entity qualifies under the 1938 Grandfather Clause, contained in section 20l(p)(l) of the U.S. Federal Food, Drug and Cosmetic Act.] |
| Product Type Code | NCIT_C94031 | [A coded value specifying the kind of product.] |